Researchers have been excited about this new drug, a groundbreaking dual agonist showing promising data in early trials for weight reduction . It functions by impacting both pathways : GLP-1 and GIP, https://gerardhezb746107.uzblog.net/a-new-possibility-for-body-management-54409463